PKC/MEK inhibitors suppress oxaliplatin‐induced neuropathy and potentiate the antitumor effects

Publisher: John Wiley & Sons Inc

E-ISSN: 1097-0215|137|1|243-250

ISSN: 0020-7136

Source: INTERNATIONAL JOURNAL OF CANCER, Vol.137, Iss.1, 2015-07, pp. : 243-250

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract